Novelty and Impact: In colorectal cancer, EMT has been described at the invasive margin, but it is also thought to occur at the tumor centre. We tested a novel tumor-based EMT score that stratified survival in stage II/III patients and associated with metastasis. This combined EMT score could be utilized to identify stage II/III patients at risk of micrometastases and who may benefit from standard adjuvant therapy.
INTRODUCTION
Colorectal cancer is the third most common cancer and second largest cause of cancer death in Europe and North America 1 . Even with advances in surgery and adjuvant treatment, five-year survival rates remain low at 60% 2 . While pathological staging of the tumor remains the gold standard prognostic marker for colorectal cancer, a subset of patients within the same disease stage will have a worse outcome. Identifying these patients with aggressive disease who may benefit from adjuvant therapy remains an important clinical need.
The metastatic process of tumor cells breaking away from the primary tumor, invading locally and migrating to distant sites has been defined as epithelialmesenchymal transition (EMT). EMT is the process of de-differentiation of epithelial cells into mesenchymal cells 3 , an important component in normal inflammatory physiology. EMT can be considered to be an example of the tumor exploiting a physiological mechanism, characterized by a loss of tumor cell polarity and adhesion, increased motility and evasion of apoptosis 4 . EMT is therefore thought to be one of the initiating and enabling steps in the invasion-metastasis cascade 4 . Several welldescribed molecular markers of EMT have been validated. Down-regulation of membrane E-cadherin is considered a hallmark of EMT 4, 5 . E-cadherin is a transmembrane protein that regulates cell-cell adhesion, and is now considered to have tumor suppressive activity by maintaining cells in a non-motile, quiescent state 6 . β-catenin, a prime effector in the Wnt pathway, is another integral component of EMT 5 . It links E-cadherin to the cytoskeleton by forming a complex and this is thought to support E-cadherin's role in cell-cell adhesion 7 . The loss of E-cadherin allows β-catenin to translocate into the nucleus and increase β-catenin-dependent gene transcription of pro-metastatic factors 8 . Further upstream, a complex of proteins regulates EMT, which includes transcription factors Snail, Fascin and Zinc-fingerenhancing-binding-protein-1 (Zeb-1) 4, 5 .
Alterations in these markers have been associated with the presence of lymphatic and distant metastases in colorectal cancer resulting in poorer patient survival 4, 5 . While the prognostic significance of the individual markers is well studied at the invasive margin, the significance of these markers within the tumor centre or as a combined EMT score to help predict the patients with aggressive disease has not been established. Furthermore, the interaction between EMT and components of the tumor microenvironment is still poorly understood 9 . Therefore, the present study aims to examine the prognostic value of these five EMT markers within the tumor centre and to construct a combined EMT prognostic score to help predict patients with aggressive disease. The study will also establish the relationship between this EMT score and clinicopathological factors to establish new therapeutic targets for these patients. 
MATERIALS AND METHODS

Patient Cohort
Clinicopathological Characteristics
Tumors were staged using the fifth edition of the AJCC/UICC-TNM staging system 10 . Tumor differentiation was graded in accordance with Royal College of Pathologists 11 . The presence of venous invasion was assessed using Elastica staining.
Differentiation, margin involvement, peritoneal involvement, and necrosis were taken from pathology reports issued following resection. Ki67 was already available for this cohort using a threshold of 50%. MMR status was assessed as previously described 12 .
Patients were followed up for at least five years and date and cause of death were crosschecked with electronic case records. Cancer-specific survival (CSS) was measured from date of surgery until date of death from CRC.
Serum C-reactive protein (CRP) and albumin were recorded prospectively and measured within 30 days prior to surgery. The pre-operative systemic inflammatory response was defined using the modified Glasgow prognostic score (mGPS) as previously described 13 .
Tumor Microenvironment Characteristics
Stromal infiltration was assessed using tumor stroma percentage (TSP) as previously described 14 . The local inflammatory cell infiltrate was assessed using the KlintrupMakinen (KM) grade 15 . The Glasgow microenvironment score (GMS) was calculated as previously described 16 . Individual T-cell characterization was already available for this cohort.
Immunohistochemistry
An immunohistochemical analysis of 5 fully validated EMT markers was performed utilizing a previously constructed CRC patient TMA: Antibody visualization was performed with 3,3'-diaminobenzidine (DAB; Vector Laboratories) until colour developed. Slides were counterstained with haematoxylin and dehydrated in alcohol and Histoclear. Slides were then mounted with DPX.
Scoring Method
Stained TMA sections were scanned using a Hamamatsu NanoZoomer (Welwyn Garden City, Hertfordshire, UK) at x20 magnification and visualized on Slidepath Digital Image Hub (Leica Biosystems, Milton Keynes, UK). Assessment of EMT markers was performed by a single examiner blinded to clinical data at x20 magnification (total magnification x400) using the weighted histoscore. The weighted histoscore was calculated as follows: 0x% not stained + 1x% weakly stained + 2x% moderately stained + 3x% strongly stained. This gave a range of scores from 0 to 300 with nuclear, cytoplasmic and membrane tumor-specific staining scored separately.
For all EMT markers the four TMA cores were scored separately to ensure reproducibility and an average score taken ( Figure S1B ). 10% of tumors were also coscored by a co-investigator and the interclass correlation coefficient calculated to be <0.7 for all proteins.
Statistical Analysis
Histoscores were split into high and low expression using the median for each marker at each location. SPSS (version 22) was used for statistical analysis. Pearson's χ2 test assessed associations between EMT markers, clinicopathological features and the tumor microenvironment. Kaplan-Meier curves and log-rank analysis compared EMT markers and CSS. HRs and confidence intervals (CI) were calculated from univariate cox regression survival analysis. Multivariate cox regression survival analysis using a backward conditional elimination model and a significance threshold of p<0.05 was performed to identify independent prognostic biomarkers. The study is reported in line with the REMARK guidelines 17 and significance was set as p<0.05.
RESULTS
A total of 185 patients were studied that underwent a potentially curative resection for stage II-III CRC and had a valid score for all five EMT markers within the tumor centre. The patient characteristics for the cohort are shown in Table S1 . The median follow-up for patients was 11.4 years (range 6.8-16.0) with 62 cancer deaths and 50
non-cancer deaths.
Firstly, the cohort was assessed for associations with CSS (Table 1 ). E-cadherin and fascin did not associate with CSS at any cellular location. Membrane beta-catenin trended towards associations with improved CSS (HR 0.62 95% CI 0.37-1.02, p=0.053, figure 1A ). Conversely, zeb1 trended towards associations with decreased CSS in the cytoplasm (HR 1.57 95% CI 0.94-2.60, p=0.080, figure 1B ). However, cytoplasmic snail significantly associated with decreased survival (HR 1.94 95% CI 1.15-3.29, p=0.012, figure 1C) . Next, the five markers were analyzed for correlations to assess if they are working together (Table S2) . Strong correlations were seen between membrane e-cadherin and nuclear beta-catenin as expected (p<0.001).
Cytoplasmic snail and zeb1 also correlated with membrane e-cadherin (p=0.001 and p=0.009) and nuclear beta catenin (p=0.010 and p=0.042). Cytoplasmic zeb1 also strongly correlate with cytoplasmic fascin (p=0.005).
Therefore, membrane e-cadherin, nuclear beta-catenin and cytoplasmic fascin, snail and zeb1 were combined to create a combined EMT score. Patients with high membrane e-cadherin and low expression of all other markers were grouped as absent EMT, patients with low membrane e-cadherin or high expression of any of the other markers were grouped as low EMT and patients with low membrane e-cadherin and high expression of all other markers were grouped as high EMT. A high EMT score was significantly associated with decreased CSS (HR 3.86 95% CI 2.17-6.86, p<0.001, Figure 1D ). As MMR deficient tumors are known to lack aggressive invasive features associated with EMT and therefore could be a confounding factor; these patients were removed from the cohort. However, no significant effect on the combined EMT scores association with CSS was observed (HR 3.79 95% CI 2.02-7.11, p<0.001) therefore all future analysis was performed utilizing the full cohort.
Cytoplasmic snail and the combined EMT score were then assessed for associations with clinicopathological factors as shown in Table 2 . Patients with high cytoplasmic snail were more likely to have received adjuvant therapy (p=0.007) and trended towards having a high mGPS (p=0.060). Similarly, patients with a high EMT score were more likely to have increased tumor budding (p=0.046) and an increased mGPS (p=0.007). A trend towards increased venous invasion (p=0.055) and decreased local inflammation was also seen (p=0.157). A high combined EMT score also showed increased lymph node metastasis levels, which was not seen for absent or low EMT scores ( Figure 2A ).
To assess if the trend towards decreased inflammation was dependent on a specific lymphocyte population, associations were assessed as shown in Table 3 . Cytoplasmic snail associated with decreased T regulatory cells within the stroma (p=0.006) and tumor centre (p=0.006). Similarly, the combined EMT score associated with decreased stromal T-regulatory cells (p=0.049) but also marginal memory T-cells (p=0.035) and stromal memory T-cells (p=0.030). When assessed for expression for each score, only patients with a high EMT score had decreased levels of CD8+ cytotoxic ( Figure 2B ), CD45RO+ memory ( Figure 2C ) and Fox3P+ regulatory ( Figure 2D ) T-cells.
Cytoplasmic snail and the combined EMT score were then taken forwards into multivariate analysis with common clinicopathological factors ( 
DISCUSSION
The results of the present study show that both cytoplasmic snail and a novel combined EMT score stratify patients with stage II/III CRC by survival, with high expression having the worst prognosis. Furthermore, the combined EMT score is associated with increased tumor budding, invasion into blood vessels, and lymph node invasion suggesting it is a key factor in tumor metastasis. Therefore, blockade of EMT in stage II/III patients may be a potential therapeutic route to inhibit metastatic spread, allowing surgical resection of the primary tumor to be a curative procedure.
Multiple studies have elucidated the clinical value of individual EMT markers at the invasive margin of CRC 18 . Decreased membrane e-cadherin expression and increased nuclear beta-catenin expression have consistently been described as prognostic markers in colorectal cancer 19, 20 . Furthermore, Bhangu et al. reported that reduced ecadherin and increased nuclear beta-catenin expression at the invasive margin can predict patients who will not respond to neoadjuvant therapy 21 . Hao et al. also
reported that reduced expression of membrane beta-catenin was associated with colorectal adenoma-carcinoma progression 22 . Furthermore, the association between reduced membrane beta-catenin expression and poor survival has been reported widely [23] [24] [25] [26] . However, increasingly, studies have disputed that EMT only occurs at this site.
Kroepil et al. reported similar expression levels of e-cadherin and snail at the tumor centre and invasive margin 27 . Kahlert et al. reported raised expressions of zeb-2 in both tumor centre and invasive margin compared with normal colorectal tissue and both were correlated with outcome 28 . Several other studies using TMAs in which the cores are taken from non-selected areas of the tumor, have also reported consistent relationships between markers of EMT (beta-catenin, e-cadherin, zeb-1, snail and fascin-1) and clinical outcome [29] [30] [31] . This is in agreement with the present study that shows high expression of cytoplasmic snail is associated with decreased survival in a TMA constructed from the centre of the tumor confirming that EMT marker alterations are observable in the tumor centre and can be used to predict prognosis.
Furthermore, snail has value as a therapeutic target, with the snail inhibitor MRX34, undergoing a phase I trial in advanced cancers. The trial not only showed that the drug was tolerable but that it also had anti-tumor activity via EMT inhibition in hepatocellular carcinoma patients, suggesting it may be a suitable therapeutic for other EMT-related cancers 32 .
The value of EMT markers for prognosis and therapeutic intervention is further strengthened by the results of our combined EMT score utilizing five markers of EMT from the tumor centre. The combined EMT score strongly stratified patient survival and was independent of TNM-stage. The prognostic power of the combined score was far superior to that of any of the individual markers, suggesting the pathway needs to be assessed as a whole to fully elucidate its prognostic role in CRC. To the authors knowledge, this is the first combined EMT score tested for CRC. Kim et al. did report a combined score for EMT using nine markers in gastric cancer with similar associations with survival 33 . However, as the current combined EMT score only uses five markers it may be more readily translated to the clinical setting. The combined EMT score also associated with well-established markers of metastasis. Furthermore, associations were also seen with increased systemic inflammation along with a trend towards decreased local inflammation suggesting the tumor microenvironment may play a role in regulating EMT.
There has been limited studies showing that the tumor microenvironment interacts with the EMT process 9 . It has been shown that tumor-associated macrophages promote the invasion-metastasis cascade 9 . However, associations between EMT and the local inflammatory response have not been reported. In the present study increased EMT associates with decreased memory and regulatory T-cells at the margin and within the stroma. This decrease in regulatory T-cells was also seen for cytoplasmic snail. This suggests that local inflammation may antagonize EMT within the tumor-centre, therefore as inflammation decreases EMT can increase to promote lymph node metastasis as seen in patients with a high EMT (Figure 2 ).
In conclusion, the findings of the present study indicate that elucidating the presence of EMT markers together within the combined EMT score may allow selection of clinical trials are currently active, however translational research has shown that metformin has promise as an inhibitor of EMT with anti-cancer activity 34 . This lack of CRC clinical trials suggests that a biomarker such as the combined EMT score is needed to stratify CRC patients for EMT inhibitor clinical trials +/-adjuvant therapy.
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